                         SEQUENCE LISTING

<110>  Follicum AB
 
<120>  Peptides for treatment of diabetes

<130>  P4428EP00

<160>  187   

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  peptide, FOL-005

<400>  1

Val Asp Thr Tyr Asp Gly Asp Ile Ser Val Val Tyr Gly Leu Arg 
1               5                   10                  15  


<210>  2
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  peptide

<400>  2

Val Asp Thr Tyr Asp Gly Asp Ile Ser Val Val Tyr Gly Leu Ser 
1               5                   10                  15  


<210>  3
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  peptide, FOL-025

<400>  3

Val Asp Thr Tyr Asp Gly Asp Ile Ser Val Val Tyr Gly Leu 
1               5                   10                  


<210>  4
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  peptide

<400>  4

Asp Thr Tyr Asp Gly Asp Ile Ser Val Val Tyr Gly Leu Arg 
1               5                   10                  


<210>  5
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  peptide

<400>  5

Thr Tyr Asp Gly Asp Ile Ser Val Val Tyr Gly Leu Arg Ser 
1               5                   10                  


<210>  6
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(13)
<223>  peptide, FOL-024

<400>  6

Val Asp Thr Tyr Asp Gly Asp Ile Ser Val Val Tyr Gly 
1               5                   10              


<210>  7
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(13)
<223>  peptide

<400>  7

Asp Thr Tyr Asp Gly Asp Ile Ser Val Val Tyr Gly Leu 
1               5                   10              


<210>  8
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(13)
<223>  peptide

<400>  8

Thr Tyr Asp Gly Asp Ile Ser Val Val Tyr Gly Leu Arg 
1               5                   10              


<210>  9
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(13)
<223>  peptide

<400>  9

Tyr Asp Gly Asp Ile Ser Val Val Tyr Gly Leu Arg Ser 
1               5                   10              


<210>  10
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(12)
<223>  peptide

<400>  10

Val Asp Thr Tyr Asp Gly Asp Ile Ser Val Val Tyr 
1               5                   10          


<210>  11
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(12)
<223>  peptide

<400>  11

Asp Thr Tyr Asp Gly Asp Ile Ser Val Val Tyr Gly 
1               5                   10          


<210>  12
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(12)
<223>  peptide

<400>  12

Thr Tyr Asp Gly Asp Ile Ser Val Val Tyr Gly Leu 
1               5                   10          


<210>  13
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(12)
<223>  peptide

<400>  13

Tyr Asp Gly Asp Ile Ser Val Val Tyr Gly Leu Arg 
1               5                   10          


<210>  14
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(12)
<223>  peptide

<400>  14

Asp Gly Asp Ile Ser Val Val Tyr Gly Leu Arg Ser 
1               5                   10          


<210>  15
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  peptide

<400>  15

Val Asp Thr Tyr Asp Gly Asp Ile Ser Val Val 
1               5                   10      


<210>  16
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  peptide

<400>  16

Asp Thr Tyr Asp Gly Asp Ile Ser Val Val Tyr 
1               5                   10      


<210>  17
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  peptide

<400>  17

Thr Tyr Asp Gly Asp Ile Ser Val Val Tyr Gly 
1               5                   10      


<210>  18
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  peptide

<400>  18

Tyr Asp Gly Asp Ile Ser Val Val Tyr Gly Leu 
1               5                   10      


<210>  19
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  peptide

<400>  19

Asp Gly Asp Ile Ser Val Val Tyr Gly Leu Arg 
1               5                   10      


<210>  20
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  peptide

<400>  20

Gly Asp Ile Ser Val Val Tyr Gly Leu Arg Ser 
1               5                   10      


<210>  21
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(10)
<223>  peptide

<400>  21

Val Asp Thr Tyr Asp Gly Asp Ile Ser Val 
1               5                   10  


<210>  22
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(10)
<223>  peptide

<400>  22

Asp Thr Tyr Asp Gly Asp Ile Ser Val Val 
1               5                   10  


<210>  23
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(10)
<223>  peptide

<400>  23

Thr Tyr Asp Gly Asp Ile Ser Val Val Tyr 
1               5                   10  


<210>  24
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(10)
<223>  peptide

<400>  24

Tyr Asp Gly Asp Ile Ser Val Val Tyr Gly 
1               5                   10  


<210>  25
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(10)
<223>  peptide

<400>  25

Asp Gly Asp Ile Ser Val Val Tyr Gly Leu 
1               5                   10  


<210>  26
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(10)
<223>  peptide, FOL-009h

<400>  26

Gly Asp Ile Ser Val Val Tyr Gly Leu Arg 
1               5                   10  


<210>  27
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(10)
<223>  peptide

<400>  27

Asp Ile Ser Val Val Tyr Gly Leu Arg Ser 
1               5                   10  


<210>  28
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  peptide, FOL-019h

<400>  28

Val Asp Thr Tyr Asp Gly Asp Ile Ser 
1               5                   


<210>  29
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  peptide

<400>  29

Asp Thr Tyr Asp Gly Asp Ile Ser Val 
1               5                   


<210>  30
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  peptide

<400>  30

Thr Tyr Asp Gly Asp Ile Ser Val Val 
1               5                   


<210>  31
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  peptide

<400>  31

Tyr Asp Gly Asp Ile Ser Val Val Tyr 
1               5                   


<210>  32
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  peptide

<400>  32

Asp Gly Asp Ile Ser Val Val Tyr Gly 
1               5                   


<210>  33
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  peptide

<400>  33

Gly Asp Ile Ser Val Val Tyr Gly Leu 
1               5                   


<210>  34
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  peptide

<400>  34

Asp Ile Ser Val Val Tyr Gly Leu Arg 
1               5                   


<210>  35
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  peptide

<400>  35

Ile Ser Val Val Tyr Gly Leu Arg Ser 
1               5                   


<210>  36
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  peptide

<400>  36

Val Asp Thr Tyr Asp Gly Asp Ile 
1               5               


<210>  37
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  peptide

<400>  37

Asp Thr Tyr Asp Gly Asp Ile Ser 
1               5               


<210>  38
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  peptide

<400>  38

Thr Tyr Asp Gly Asp Ile Ser Val 
1               5               


<210>  39
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  peptide

<400>  39

Tyr Asp Gly Asp Ile Ser Val Val 
1               5               


<210>  40
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  peptide

<400>  40

Asp Gly Asp Ile Ser Val Val Tyr 
1               5               


<210>  41
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  peptide

<400>  41

Gly Asp Ile Ser Val Val Tyr Gly 
1               5               


<210>  42
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  peptide

<400>  42

Asp Ile Ser Val Val Tyr Gly Leu 
1               5               


<210>  43
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  peptide

<400>  43

Ile Ser Val Val Tyr Gly Leu Arg 
1               5               


<210>  44
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  44

Val Asp Thr Tyr Asp Gly Asp 
1               5           


<210>  45
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  45

Asp Thr Tyr Asp Gly Asp Ile 
1               5           


<210>  46
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  46

Thr Tyr Asp Gly Asp Ile Ser 
1               5           


<210>  47
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  47

Tyr Asp Gly Asp Ile Ser Val 
1               5           


<210>  48
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  48

Asp Gly Asp Ile Ser Val Val 
1               5           


<210>  49
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  49

Gly Asp Ile Ser Val Val Tyr 
1               5           


<210>  50
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  50

Asp Ile Ser Val Val Tyr Gly 
1               5           


<210>  51
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  51

Ile Ser Val Val Tyr Gly Leu 
1               5           


<210>  52
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(6)
<223>  peptide

<400>  52

Asp Thr Tyr Asp Gly Asp 
1               5       


<210>  53
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(6)
<223>  peptide

<400>  53

Thr Tyr Asp Gly Asp Ile 
1               5       


<210>  54
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(6)
<223>  peptide

<400>  54

Tyr Asp Gly Asp Ile Ser 
1               5       


<210>  55
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(6)
<223>  peptide

<400>  55

Asp Gly Asp Ile Ser Val 
1               5       


<210>  56
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(6)
<223>  peptide

<400>  56

Gly Asp Ile Ser Val Val 
1               5       


<210>  57
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(6)
<223>  peptide

<400>  57

Asp Ile Ser Val Val Tyr 
1               5       


<210>  58
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(6)
<223>  peptide

<400>  58

Ile Ser Val Val Tyr Gly 
1               5       


<210>  59
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  peptide

<400>  59

Thr Tyr Asp Gly Asp 
1               5   


<210>  60
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  peptide

<400>  60

Tyr Asp Gly Asp Ile 
1               5   


<210>  61
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  peptide

<400>  61

Asp Gly Asp Ile Ser 
1               5   


<210>  62
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  peptide

<400>  62

Gly Asp Ile Ser Val 
1               5   


<210>  63
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  peptide

<400>  63

Asp Ile Ser Val Val 
1               5   


<210>  64
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  peptide

<400>  64

Ile Ser Val Val Tyr 
1               5   


<210>  65
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  peptide

<400>  65

Ser Val Val Tyr Gly 
1               5   


<210>  66
<211>  300
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<222>  (1)..(300)
<223>  Wildtype human osteopontin

<400>  66

Met Arg Ile Ala Val Ile Cys Phe Cys Leu Leu Gly Ile Thr Cys Ala 
1               5                   10                  15      


Ile Pro Val Lys Gln Ala Asp Ser Gly Ser Ser Glu Glu Lys Gln Leu 
            20                  25                  30          


Tyr Asn Lys Tyr Pro Asp Ala Val Ala Thr Trp Leu Asn Pro Asp Pro 
        35                  40                  45              


Ser Gln Lys Gln Asn Leu Leu Ala Pro Gln Thr Leu Pro Ser Lys Ser 
    50                  55                  60                  


Asn Glu Ser His Asp His Met Asp Asp Met Asp Asp Glu Asp Asp Asp 
65                  70                  75                  80  


Asp His Val Asp Ser Gln Asp Ser Ile Asp Ser Asn Asp Ser Asp Asp 
                85                  90                  95      


Val Asp Asp Thr Asp Asp Ser His Gln Ser Asp Glu Ser His His Ser 
            100                 105                 110         


Asp Glu Ser Asp Glu Leu Val Thr Asp Phe Pro Thr Asp Leu Pro Ala 
        115                 120                 125             


Thr Glu Val Phe Thr Pro Val Val Pro Thr Val Asp Thr Tyr Asp Gly 
    130                 135                 140                 


Arg Gly Asp Ser Val Val Tyr Gly Leu Arg Ser Lys Ser Lys Lys Phe 
145                 150                 155                 160 


Arg Arg Pro Asp Ile Gln Tyr Pro Asp Ala Thr Asp Glu Asp Ile Thr 
                165                 170                 175     


Ser His Met Glu Ser Glu Glu Leu Asn Gly Ala Tyr Lys Ala Ile Pro 
            180                 185                 190         


Val Ala Gln Asp Leu Asn Ala Pro Ser Asp Trp Asp Ser Arg Gly Lys 
        195                 200                 205             


Asp Ser Tyr Glu Thr Ser Gln Leu Asp Asp Gln Ser Ala Glu Thr His 
    210                 215                 220                 


Ser His Lys Gln Ser Arg Leu Tyr Lys Arg Lys Ala Asn Asp Glu Ser 
225                 230                 235                 240 


Asn Glu His Ser Asp Val Ile Asp Ser Gln Glu Leu Ser Lys Val Ser 
                245                 250                 255     


Arg Glu Phe His Ser His Glu Phe His Ser His Glu Asp Met Leu Val 
            260                 265                 270         


Val Asp Pro Lys Ser Lys Glu Glu Asp Lys His Leu Lys Phe Arg Ile 
        275                 280                 285             


Ser His Glu Leu Asp Ser Ala Ser Ser Glu Val Asn 
    290                 295                 300 


<210>  67
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  peptide, FOL-002

<400>  67

Val Asp Thr Tyr Asp Gly Arg Gly Asp Ser Val Val Tyr Gly Leu Arg 
1               5                   10                  15      


<210>  68
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is T or V

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X is Y or P

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is D or N

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is D or G

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X is I or G

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is V or L

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  X is V or A

<400>  68

Val Asp Xaa Xaa Xaa Gly Xaa Xaa Ser Xaa Xaa Tyr Gly Leu Arg 
1               5                   10                  15  


<210>  69
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  peptide, FOL-004

<400>  69

Val Asp Val Pro Asn Gly Asp Ile Ser Leu Ala Tyr Gly Leu Arg 
1               5                   10                  15  


<210>  70
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  peptide

<400>  70

Asp Val Pro Asn Gly Asp Ile Ser Leu Ala Tyr Gly Leu Arg Ser 
1               5                   10                  15  


<210>  71
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  peptide

<400>  71

Val Asp Val Pro Asn Gly Asp Ile Ser Leu Ala Tyr Gly Leu 
1               5                   10                  


<210>  72
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  peptide

<400>  72

Asp Val Pro Asn Gly Asp Ile Ser Leu Ala Tyr Gly Leu Arg 
1               5                   10                  


<210>  73
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  peptide

<400>  73

Val Pro Asn Gly Asp Ile Ser Leu Ala Tyr Gly Leu Arg Ser 
1               5                   10                  


<210>  74
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(13)
<223>  peptide, FOL-017

<400>  74

Val Asp Val Pro Asn Gly Asp Ile Ser Leu Ala Tyr Gly 
1               5                   10              


<210>  75
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(13)
<223>  peptide

<400>  75

Asp Val Pro Asn Gly Asp Ile Ser Leu Ala Tyr Gly Leu 
1               5                   10              


<210>  76
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(13)
<223>  peptide

<400>  76

Val Pro Asn Gly Asp Ile Ser Leu Ala Tyr Gly Leu Arg 
1               5                   10              


<210>  77
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(13)
<223>  peptide

<400>  77

Pro Asn Gly Asp Ile Ser Leu Ala Tyr Gly Leu Arg Ser 
1               5                   10              


<210>  78
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(12)
<223>  peptide

<400>  78

Val Asp Val Pro Asn Gly Asp Ile Ser Leu Ala Tyr 
1               5                   10          


<210>  79
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(12)
<223>  peptide

<400>  79

Asp Val Pro Asn Gly Asp Ile Ser Leu Ala Tyr Gly 
1               5                   10          


<210>  80
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(12)
<223>  peptide

<400>  80

Val Pro Asn Gly Asp Ile Ser Leu Ala Tyr Gly Leu 
1               5                   10          


<210>  81
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(12)
<223>  peptide

<400>  81

Pro Asn Gly Asp Ile Ser Leu Ala Tyr Gly Leu Arg 
1               5                   10          


<210>  82
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(12)
<223>  peptide

<400>  82

Asn Gly Asp Ile Ser Leu Ala Tyr Gly Leu Arg Ser 
1               5                   10          


<210>  83
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  peptide

<400>  83

Val Asp Val Pro Asn Gly Asp Ile Ser Leu Ala 
1               5                   10      


<210>  84
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  peptide

<400>  84

Asp Val Pro Asn Gly Asp Ile Ser Leu Ala Tyr 
1               5                   10      


<210>  85
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  peptide

<400>  85

Val Pro Asn Gly Asp Ile Ser Leu Ala Tyr Gly 
1               5                   10      


<210>  86
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  peptide

<400>  86

Pro Asn Gly Asp Ile Ser Leu Ala Tyr Gly Leu 
1               5                   10      


<210>  87
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  peptide

<400>  87

Asn Gly Asp Ile Ser Leu Ala Tyr Gly Leu Arg 
1               5                   10      


<210>  88
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  peptide

<400>  88

Gly Asp Ile Ser Leu Ala Tyr Gly Leu Arg Ser 
1               5                   10      


<210>  89
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(10)
<223>  peptide

<400>  89

Val Asp Val Pro Asn Gly Asp Ile Ser Leu 
1               5                   10  


<210>  90
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(10)
<223>  peptide

<400>  90

Asp Val Pro Asn Gly Asp Ile Ser Leu Ala 
1               5                   10  


<210>  91
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(10)
<223>  peptide

<400>  91

Val Pro Asn Gly Asp Ile Ser Leu Ala Tyr 
1               5                   10  


<210>  92
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(10)
<223>  peptide

<400>  92

Pro Asn Gly Asp Ile Ser Leu Ala Tyr Gly 
1               5                   10  


<210>  93
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(10)
<223>  peptide

<400>  93

Asn Gly Asp Ile Ser Leu Ala Tyr Gly Leu 
1               5                   10  


<210>  94
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(10)
<223>  peptide, FOL-009

<400>  94

Gly Asp Ile Ser Leu Ala Tyr Gly Leu Arg 
1               5                   10  


<210>  95
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(10)
<223>  peptide

<400>  95

Asp Ile Ser Leu Ala Tyr Gly Leu Arg Ser 
1               5                   10  


<210>  96
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  peptide, FOL-019

<400>  96

Val Asp Val Pro Asn Gly Asp Ile Ser 
1               5                   


<210>  97
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  peptide

<400>  97

Asp Val Pro Asn Gly Asp Ile Ser Leu 
1               5                   


<210>  98
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  peptide

<400>  98

Val Pro Asn Gly Asp Ile Ser Leu Ala 
1               5                   


<210>  99
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  peptide

<400>  99

Pro Asn Gly Asp Ile Ser Leu Ala Tyr 
1               5                   


<210>  100
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  peptide

<400>  100

Asn Gly Asp Ile Ser Leu Ala Tyr Gly 
1               5                   


<210>  101
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  peptide

<400>  101

Gly Asp Ile Ser Leu Ala Tyr Gly Leu 
1               5                   


<210>  102
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  peptide

<400>  102

Asp Ile Ser Leu Ala Tyr Gly Leu Arg 
1               5                   


<210>  103
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  peptide

<400>  103

Ile Ser Leu Ala Tyr Gly Leu Arg Ser 
1               5                   


<210>  104
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  peptide

<400>  104

Val Asp Val Pro Asn Gly Asp Ile 
1               5               


<210>  105
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  peptide

<400>  105

Asp Val Pro Asn Gly Asp Ile Ser 
1               5               


<210>  106
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  peptide

<400>  106

Val Pro Asn Gly Asp Ile Ser Leu 
1               5               


<210>  107
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  peptide

<400>  107

Pro Asn Gly Asp Ile Ser Leu Ala 
1               5               


<210>  108
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  peptide

<400>  108

Asn Gly Asp Ile Ser Leu Ala Tyr 
1               5               


<210>  109
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  peptide

<400>  109

Gly Asp Ile Ser Leu Ala Tyr Gly 
1               5               


<210>  110
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  peptide

<400>  110

Asp Ile Ser Leu Ala Tyr Gly Leu 
1               5               


<210>  111
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  peptide

<400>  111

Ile Ser Leu Ala Tyr Gly Leu Arg 
1               5               


<210>  112
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  112

Val Asp Val Pro Asn Gly Asp 
1               5           


<210>  113
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  113

Asp Val Pro Asn Gly Asp Ile 
1               5           


<210>  114
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  114

Val Pro Asn Gly Asp Ile Ser 
1               5           


<210>  115
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  115

Pro Asn Gly Asp Ile Ser Leu 
1               5           


<210>  116
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  116

Asn Gly Asp Ile Ser Leu Ala 
1               5           


<210>  117
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  117

Gly Asp Ile Ser Leu Ala Tyr 
1               5           


<210>  118
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  118

Asp Ile Ser Leu Ala Tyr Gly 
1               5           


<210>  119
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  119

Ile Ser Leu Ala Tyr Gly Leu 
1               5           


<210>  120
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(6)
<223>  peptide

<400>  120

Asp Val Pro Asn Gly Asp 
1               5       


<210>  121
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(6)
<223>  peptide

<400>  121

Val Pro Asn Gly Asp Ile 
1               5       


<210>  122
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(6)
<223>  peptide

<400>  122

Pro Asn Gly Asp Ile Ser 
1               5       


<210>  123
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(6)
<223>  peptide

<400>  123

Asn Gly Asp Ile Ser Leu 
1               5       


<210>  124
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(6)
<223>  peptide

<400>  124

Gly Asp Ile Ser Leu Ala 
1               5       


<210>  125
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(6)
<223>  peptide

<400>  125

Asp Ile Ser Leu Ala Tyr 
1               5       


<210>  126
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(6)
<223>  peptide

<400>  126

Ile Ser Leu Ala Tyr Gly 
1               5       


<210>  127
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  peptide

<400>  127

Val Pro Asn Gly Asp 
1               5   


<210>  128
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  peptide

<400>  128

Pro Asn Gly Asp Ile 
1               5   


<210>  129
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  peptide

<400>  129

Asn Gly Asp Ile Ser 
1               5   


<210>  130
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  peptide

<400>  130

Gly Asp Ile Ser Leu 
1               5   


<210>  131
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  peptide

<400>  131

Asp Ile Ser Leu Ala 
1               5   


<210>  132
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  peptide

<400>  132

Ile Ser Leu Ala Tyr 
1               5   


<210>  133
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  peptide

<400>  133

Ser Leu Ala Tyr Gly 
1               5   


<210>  134
<211>  294
<212>  PRT
<213>  Mus musculus


<220>
<221>  MISC_FEATURE
<222>  (1)..(294)
<223>  Wildtype murine osteopontin

<400>  134

Met Arg Leu Ala Val Ile Cys Phe Cys Leu Phe Gly Ile Ala Ser Ser 
1               5                   10                  15      


Leu Pro Val Lys Val Thr Asp Ser Gly Ser Ser Glu Glu Lys Leu Tyr 
            20                  25                  30          


Ser Leu His Pro Asp Pro Ile Ala Thr Trp Leu Val Pro Asp Pro Ser 
        35                  40                  45              


Gln Lys Gln Asn Leu Leu Ala Pro Gln Asn Ala Val Ser Ser Glu Glu 
    50                  55                  60                  


Lys Asp Asp Phe Lys Gln Glu Thr Leu Pro Ser Asn Ser Asn Glu Ser 
65                  70                  75                  80  


His Asp His Met Asp Asp Asp Asp Asp Asp Asp Asp Asp Asp Gly Asp 
                85                  90                  95      


His Ala Glu Ser Glu Asp Ser Val Asp Ser Asp Glu Ser Asp Glu Ser 
            100                 105                 110         


His His Ser Asp Glu Ser Asp Glu Thr Val Thr Ala Ser Thr Gln Ala 
        115                 120                 125             


Asp Thr Phe Thr Pro Ile Val Pro Thr Val Asp Val Pro Asn Gly Arg 
    130                 135                 140                 


Gly Asp Ser Leu Ala Tyr Gly Leu Arg Ser Lys Ser Arg Ser Phe Gln 
145                 150                 155                 160 


Val Ser Asp Glu Gln Tyr Pro Asp Ala Thr Asp Glu Asp Leu Thr Ser 
                165                 170                 175     


His Met Lys Ser Gly Glu Ser Lys Glu Ser Leu Asp Val Ile Pro Val 
            180                 185                 190         


Ala Gln Leu Leu Ser Met Pro Ser Asp Gln Asp Asn Asn Gly Lys Gly 
        195                 200                 205             


Ser His Glu Ser Ser Gln Leu Asp Glu Pro Ser Leu Glu Thr His Arg 
    210                 215                 220                 


Leu Glu His Ser Lys Glu Ser Gln Glu Ser Ala Asp Gln Ser Asp Val 
225                 230                 235                 240 


Ile Asp Ser Gln Ala Ser Ser Lys Ala Ser Leu Glu His Gln Ser His 
                245                 250                 255     


Lys Phe His Ser His Lys Asp Lys Leu Val Leu Asp Pro Lys Ser Lys 
            260                 265                 270         


Glu Asp Asp Arg Tyr Leu Lys Phe Arg Ile Ser His Glu Leu Glu Ser 
        275                 280                 285             


Ser Ser Ser Glu Val Asn 
    290                 


<210>  135
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  peptide, FOL-001

<400>  135

Val Asp Val Pro Asn Gly Arg Gly Asp Ser Leu Ala Tyr Gly Leu Arg 
1               5                   10                  15      


<210>  136
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  peptide, FOL-014

<400>  136

Lys Pro Leu Ala Glu Ile Asp Ser Ile Glu Leu Ser Tyr Gly Ile Lys 
1               5                   10                  15      


<210>  137
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  peptide, FOL-003

<400>  137

Gly Asp Pro Asn Asp Gly Arg Gly Asp Ser Val Val Tyr Gly Leu Arg 
1               5                   10                  15      


<210>  138
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  peptide, FOL-026

<400>  138

Val Asp Thr Tyr Asp Gly Gly Ile Ser Val Val Tyr Gly Leu Arg 
1               5                   10                  15  


<210>  139
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  peptide, FOL-027

<400>  139

Val Asp Thr Tyr Asp Gly Asp Gly Ser Val Val Tyr Gly Leu Arg 
1               5                   10                  15  


<210>  140
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is C, P or G

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is E or G

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X is C, D or I

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is D, I, S or G

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X is S, D or G

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is E or G

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  X is S or T

<400>  140

Lys Xaa Leu Ala Xaa Xaa Xaa Xaa Ile Xaa Leu Xaa Tyr Gly Ile Lys 
1               5                   10                  15      


<210>  141
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  peptide

<400>  141

Lys Cys Leu Ala Glu Cys Asp Ser Ile Glu Leu Ser Tyr Gly Ile Lys 
1               5                   10                  15      


<210>  142
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  peptide

<400>  142

Cys Leu Ala Glu Ile Asp Ser Cys 
1               5               


<210>  143
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(18)
<223>  peptide

<400>  143

Cys Phe Lys Pro Leu Ala Glu Ile Asp Ser Ile Glu Cys Ser Tyr Gly 
1               5                   10                  15      


Ile Lys 
        


<210>  144
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  peptide

<400>  144

Lys Pro Leu Ala Glu Asp Ile Ser Ile Glu Leu Ser Tyr Gly Ile Lys 
1               5                   10                  15      


<210>  145
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  peptide

<400>  145

Lys Pro Leu Ala Glu Ile Ser Asp Ile Glu Leu Ser Tyr Gly Ile Lys 
1               5                   10                  15      


<210>  146
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  peptide

<400>  146

Lys Pro Leu Ala Glu Ile Gly Asp Ile Glu Leu Ser Tyr Gly Ile Lys 
1               5                   10                  15      


<210>  147
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  peptide

<400>  147

Lys Pro Leu Ala Glu Gly Asp Ile Glu Leu Ser Tyr Gly Ile Lys 
1               5                   10                  15  


<210>  148
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(13)
<223>  peptide

<400>  148

Lys Pro Leu Ala Glu Ile Glu Leu Ser Tyr Gly Ile Lys 
1               5                   10              


<210>  149
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  peptide

<400>  149

Lys Pro Leu Ala Glu Ile Asp Ser Ile Glu Leu Thr Tyr Gly Ile Lys 
1               5                   10                  15      


<210>  150
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  peptide

<400>  150

Lys Pro Leu Ala Glu Ile Asp Gly Ile Glu Leu Ser Tyr Gly Ile Lys 
1               5                   10                  15      


<210>  151
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  peptide

<400>  151

Lys Pro Leu Ala Glu Ile Asp Gly Ile Glu Leu Thr Tyr Gly Ile Lys 
1               5                   10                  15      


<210>  152
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  peptide

<400>  152

Lys Pro Leu Ala Glu Ile Gly Ser Ile Glu Leu Ser Tyr Gly Ile Lys 
1               5                   10                  15      


<210>  153
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  peptide

<400>  153

Lys Gly Leu Ala Glu Ile Asp Ser Ile Glu Leu Ser Tyr Gly Ile Lys 
1               5                   10                  15      


<210>  154
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  peptide

<400>  154

Lys Pro Leu Ala Gly Ile Asp Ser Ile Gly Leu Ser Tyr Gly Ile Lys 
1               5                   10                  15      


<210>  155
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  peptide

<400>  155

Lys Cys Leu Ala Glu Ile Asp Ser Cys Glu Leu Ser Tyr Gly Ile Lys 
1               5                   10                  15      


<210>  156
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(13)
<223>  peptide

<400>  156

Cys Phe Lys Pro Leu Ala Glu Ile Asp Ser Ile Glu Cys 
1               5                   10              


<210>  157
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  peptide

<400>  157

Val Asp Val Pro Glu Gly Asp Ile Ser Leu Ala Tyr Gly Leu Arg 
1               5                   10                  15  


<210>  158
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  peptide

<400>  158

Leu Asp Gly Leu Val Arg Ala Tyr Asp Asn Ile Ser Pro Val Gly 
1               5                   10                  15  


<210>  159
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  peptide

<400>  159

Gly Asp Pro Asn Gly Asp Ile Ser Val Val Tyr Gly Leu Arg 
1               5                   10                  


<210>  160
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  peptide

<400>  160

Val Asp Val Pro Asn Gly Asp Ile Ser Leu Ala Tyr Arg Leu Arg 
1               5                   10                  15  


<210>  161
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  peptide

<400>  161

Val Asp Val Pro Glu Gly Asp Ile Ser Leu Ala Tyr Arg Leu Arg 
1               5                   10                  15  


<210>  162
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is C, P or G

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is E or G

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X is C, I or absent

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is D, G or absent

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X is S, G or absent

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is E or G

<400>  162

Lys Xaa Leu Ala Xaa Xaa Xaa Xaa Ile Xaa Leu Ser Tyr Gly Ile Lys 
1               5                   10                  15      


<210>  163
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(13)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is C, P or G

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is E or G

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is E or G

<400>  163

Lys Xaa Leu Ala Xaa Ile Xaa Leu Ser Tyr Gly Ile Lys 
1               5                   10              


<210>  164
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is E or N

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  X is R or G

<400>  164

Val Asp Val Pro Xaa Gly Asp Ile Ser Leu Ala Tyr Xaa Leu Arg 
1               5                   10                  15  


<210>  165
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is D or G

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X is I or G

<400>  165

Val Asp Thr Tyr Asp Gly Xaa Xaa Ser Val Val Tyr Gly Leu Arg 
1               5                   10                  15  


<210>  166
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Z is D or G

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X is D or G

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is I or R

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X is G or absent

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  X is D or absent

<400>  166

Gly Asp Pro Asn Xaa Xaa Xaa Xaa Xaa Ser Val Val Tyr Gly Leu Arg 
1               5                   10                  15      


<210>  167
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is beta D

<400>  167

Val Xaa Thr Tyr Asp Gly Asp Ile Ser Val Val Tyr Gly Leu Arg 
1               5                   10                  15  


<210>  168
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is beta D

<400>  168

Val Asp Thr Tyr Xaa Gly Asp Ile Ser Val Val Tyr Gly Leu Arg 
1               5                   10                  15  


<210>  169
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is beta D

<400>  169

Val Asp Thr Tyr Asp Gly Xaa Ile Ser Val Val Tyr Gly Leu Arg 
1               5                   10                  15  


<210>  170
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  peptide

<400>  170

Leu Ala Glu Ile Asp Ser Ile Glu Leu Ser Tyr Gly Ile Lys 
1               5                   10                  


<210>  171
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(13)
<223>  peptide, FOL-056

<400>  171

Ala Glu Ile Asp Ser Ile Glu Leu Ser Tyr Gly Ile Lys 
1               5                   10              


<210>  172
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(12)
<223>  peptide, FOL-057

<400>  172

Glu Ile Asp Ser Ile Glu Leu Ser Tyr Gly Ile Lys 
1               5                   10          


<210>  173
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  peptide, FOL-058

<400>  173

Ile Asp Ser Ile Glu Leu Ser Tyr Gly Ile Lys 
1               5                   10      


<210>  174
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(10)
<223>  peptide, FOL-059

<400>  174

Asp Ser Ile Glu Leu Ser Tyr Gly Ile Lys 
1               5                   10  


<210>  175
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  peptide, FOL-060

<400>  175

Ser Ile Glu Leu Ser Tyr Gly Ile Lys 
1               5                   


<210>  176
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  peptide

<400>  176

Ile Glu Leu Ser Tyr Gly Ile Lys 
1               5               


<210>  177
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is E or G

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is S or T

<400>  177

Xaa Leu Xaa Tyr Gly Ile Lys 
1               5           


<210>  178
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is D or G

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is I or G

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X is V or L

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is V or A

<400>  178

Xaa Xaa Ser Xaa Xaa Tyr Gly Leu Arg 
1               5                   


<210>  179
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  peptide

<400>  179

Lys Pro Leu Ala Glu Ile Asp Ser Ile Glu Leu Ser Tyr Gly Ile 
1               5                   10                  15  


<210>  180
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  peptide

<400>  180

Lys Pro Leu Ala Glu Ile Asp Ser Ile Glu Leu Ser Tyr Gly 
1               5                   10                  


<210>  181
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(13)
<223>  peptide

<400>  181

Lys Pro Leu Ala Glu Ile Asp Ser Ile Glu Leu Ser Tyr 
1               5                   10              


<210>  182
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(12)
<223>  peptide

<400>  182

Lys Pro Leu Ala Glu Ile Asp Ser Ile Glu Leu Ser 
1               5                   10          


<210>  183
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  peptide

<400>  183

Lys Pro Leu Ala Glu Ile Asp Ser Ile Glu Leu 
1               5                   10      


<210>  184
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(10)
<223>  peptide

<400>  184

Lys Pro Leu Ala Glu Ile Asp Ser Ile Glu 
1               5                   10  


<210>  185
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(25)
<223>  peptide, FOL-199

<400>  185

Gly Lys Tyr Gly Phe Tyr Thr His Val Phe Arg Leu Lys Lys Trp Ile 
1               5                   10                  15      


Gln Lys Val Ile Asp Gln Phe Gly Glu 
            20                  25  


<210>  186
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  peptide, oxytocin

<400>  186

Cys Tyr Ile Gln Asn Cys Pro Leu Gly 
1               5                   


<210>  187
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(37)
<223>  peptide, LL-37

<400>  187

Leu Leu Gly Asp Phe Phe Arg Lys Ser Lys Glu Lys Ile Gly Lys Glu 
1               5                   10                  15      


Phe Lys Arg Ile Val Gln Arg Ile Lys Asp Phe Leu Arg Asn Leu Val 
            20                  25                  30          


Pro Arg Thr Glu Ser 
        35          


